Bain Capital Life Sciences Partners, LP, 10% Owner, Director at Dicerna Pharmaceuticals Inc (DRNA), sold 1,750,000 shares at $22.03 ($38.6M) on 2019-11-19, disclosed to the SEC on 2019-11-21.
Open-market sale of $38.6M DRNA by 10% Owner, Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.